M Simányi

418 total citations
25 papers, 293 citations indexed

About

M Simányi is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, M Simányi has authored 25 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in M Simányi's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Alzheimer's disease research and treatments (3 papers) and Enzyme function and inhibition (2 papers). M Simányi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Alzheimer's disease research and treatments (3 papers) and Enzyme function and inhibition (2 papers). M Simányi collaborates with scholars based in Austria, United States and Switzerland. M Simányi's co-authors include W Danielczyk, Peter Fischer, Gerald Gatterer, Peter Fischer, Ferenc Müller, K. Jellinger, Thomas Brücke, F Gerstenbrand, M. Streifler and Mario E. Götz and has published in prestigious journals such as American Journal of Psychiatry, Acta Psychiatrica Scandinavica and Journal of Neurology.

In The Last Decade

M Simányi

23 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Simányi Austria 9 150 95 73 53 39 25 293
Leon J. Thai United States 6 212 1.4× 60 0.6× 157 2.2× 37 0.7× 22 0.6× 6 317
T. John Rosen United States 8 167 1.1× 93 1.0× 109 1.5× 47 0.9× 39 1.0× 10 382
François Boiler United States 9 262 1.7× 122 1.3× 199 2.7× 84 1.6× 27 0.7× 17 546
S Brion United States 10 126 0.8× 94 1.0× 35 0.5× 32 0.6× 75 1.9× 37 410
Carrie A. Young United States 6 348 2.3× 53 0.6× 52 0.7× 18 0.3× 18 0.5× 6 392
Brandon Martin United States 9 114 0.8× 48 0.5× 26 0.4× 39 0.7× 101 2.6× 14 377
Nicholas Kozauer United States 6 243 1.6× 68 0.7× 226 3.1× 60 1.1× 39 1.0× 10 527
Marta Zuffi Italy 10 262 1.7× 100 1.1× 128 1.8× 42 0.8× 27 0.7× 18 483
Shirish Patel United States 7 223 1.5× 72 0.8× 61 0.8× 26 0.5× 66 1.7× 8 415
L. Traykov France 8 243 1.6× 39 0.4× 117 1.6× 48 0.9× 30 0.8× 20 474

Countries citing papers authored by M Simányi

Since Specialization
Citations

This map shows the geographic impact of M Simányi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Simányi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Simányi more than expected).

Fields of papers citing papers by M Simányi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Simányi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Simányi. The network helps show where M Simányi may publish in the future.

Co-authorship network of co-authors of M Simányi

This figure shows the co-authorship network connecting the top 25 collaborators of M Simányi. A scholar is included among the top collaborators of M Simányi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Simányi. M Simányi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Danielczyk, W, et al.. (2009). Ideomotor apraxia in Alzheimer's disease. Acta Neurologica Scandinavica. 88(1). 1–4. 7 indexed citations
2.
Simányi, M. (1999). [Use of special Ginkgo biloba extract for cognitive disorders in the elderly].. PubMed. 149(8-10). 231–4. 2 indexed citations
3.
Götz, Mario E., Peter Fischer, W. Gsell, et al.. (1998). Platelet Monoamine Oxidase B Activity in Dementia. Dementia and Geriatric Cognitive Disorders. 9(2). 74–77. 23 indexed citations
4.
Danielczyk, W, et al.. (1996). Calculation abilities in dementia of Alzheimer's type and in vascular dementia. Archives of Gerontology and Geriatrics. 23(2). 189–197. 22 indexed citations
5.
Danielczyk, W, et al.. (1992). Release signs in Parkinson's disease with and without dementia. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 4(3). 207–212. 7 indexed citations
6.
Fischer, Peter, W Danielczyk, K. A. Jellinger, et al.. (1991). Clinico pathological classification of dementia. Der Nervenarzt. 62(7). 408–414. 1 indexed citations
7.
Fischer, Peter, W Danielczyk, K. A. Jellinger, et al.. (1991). [Differential diagnosis of dementia diseases. A prospective clinical study with neuropathologic diagnostic verification].. PubMed. 62(7). 408–14. 4 indexed citations
8.
Fischer, Peter, et al.. (1990). Course characteristics in the differentiation of dementia of the Alzheimer type and multi‐infarct dementia. Acta Psychiatrica Scandinavica. 81(6). 551–553. 37 indexed citations
9.
Fischer, Peter, et al.. (1990). Memory deficits in advanced Parkinson's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 2(1). 59–70. 20 indexed citations
10.
Fischer, Peter, et al.. (1990). Dopaminergic psychosis in advanced Parkinson's disease.. PubMed. 53. 391–7. 27 indexed citations
11.
Gatterer, Gerald, Peter Fischer, M Simányi, & W Danielczyk. (1989). The A-K-T ("Alters-Konzentrations-Test") a new psychometric test for geriatric patients.. PubMed. 4(3). 273–6. 14 indexed citations
12.
Streifler, M., M Simányi, Peter Fischer, & W Danielczyk. (1989). EEG- and cognitive changes in Alzheimer's disease (AD) and senile dementia of AD-type (SDAT). Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 1(1-2). 27–27. 1 indexed citations
13.
Danielczyk, W, Peter Fischer, Gerald Gatterer, & M Simányi. (1989). Depression in the course of MID and DAT. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 1(1-2). 44–44. 2 indexed citations
14.
Simányi, M, et al.. (1978). [Diurnal variations of human serum amino acid concentration].. PubMed. 5(1). 8–11. 1 indexed citations
16.
Gerstenbrand, F, et al.. (1972). [Biochemical aspects of the effect of L-dopa in patients with Parkinson's disease].. PubMed. 203(1). 73–90. 1 indexed citations
17.
Gerstenbrand, F, et al.. (1972). Biochemische Aspekte der l-DOPA-Wirkung bei Parkinsonpatienten. Journal of Neurology. 203(1). 73–90. 2 indexed citations
18.
Gerstenbrand, F, et al.. (1971). [Changes and composition of liquor cerebrospinalis and serum in amyotrophic lateralsclerosis].. PubMed. 42(2). 93–7. 3 indexed citations
19.
Gerstenbrand, F, et al.. (1969). [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. II. Alterations of cerebrospinal fluid in patients with Parkinson's disease and chorea following the administration of alpha-methyldopa].. PubMed. 196(3). 256–65. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026